Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q4 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (NASDAQ:NASDAQ:MDNA) Q4 2022 Earnings Conference Call June 22, 2022 8:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Fahar Merchant - President...

Related Keywords

Canada ,United States ,Brookline ,Massachusetts ,Boston ,Australia ,Japan ,Japanese ,Canadian ,Kumar Raja ,Matt Biegler ,David Martin ,Liz Williams ,Swayampakula Ramakanth ,Martin Bexon ,Shubhendu Roy ,David Bautz ,Andre Uddin ,Catherine Novack ,Company Participants ,Cap Research ,Development Advisory Committee ,Mackie Research Capital ,Nasdaq ,Medicenna Therapeutics Corp ,Research Capital ,Zacks Research ,Medicenna Therapeutics ,Conference Call June ,Medicenna Therapeutics Fiscal Year End Earnings ,Dan Ferry ,Annual Information Form ,Fahar Merchant ,Chief Executive Officer ,Acting Chief Medical Officer ,Chief Financial ,Bifunctional Superkines ,Clinical Advisory ,Cytokine Summit ,